The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlue Star Regulatory News (BLU)

Share Price Information for Blue Star (BLU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.03
Bid: 0.025
Ask: 0.035
Change: -0.0025 (-7.69%)
Spread: 0.01 (40.00%)
Open: 0.0325
High: 0.0325
Low: 0.03
Prev. Close: 0.0325
BLU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Loan Conversion & Director Share Issue

30 Dec 2013 07:00

RNS Number : 5073W
Blue Star Capital plc
30 December 2013
 



30 December 2013

 

 

Blue Star Capital plc

("Blue Star" or the "Company")

 

Loan conversion and director share issue

 

 

Further to the announcement on 24 December 2013, Blue Star announces that Anthony Fabrizi, CEO of the Company, has agreed to convert a portion of the outstanding amount owed to him into equity by the Company under the shareholder loan ("the Loan") entered into on 28 April 2011 and thereafter subsequently extended to the end of January 2014. In addition, the Company announces that it has repaid £96,000 of the Loan ("the Repayment").

 

Loan conversion

 

Anthony Fabrizi (the "Loan Holders") has agreed to convert £26,000 of the Loan (the "Conversion") at a price of 0.5p per share, the same terms as the recent loan conversions, into 5,200,000 new ordinary shares in the capital of the Company ("Loan Conversion Shares").

 

Following the Conversion and Repayment, the amount outstanding under the Loan (including interest and repayment premium already accrued) will be £85,292 ("Revised Principal"). To preserve Company cash and aid the implementation of the Company's investing policy, the Loan Holders have previously agreed to waive interest on the Loan until end January 2014, being the final redemption date for the Loan.

 

Application has been made for the Loan Conversion Shares, Consideration Shares and the Subscription Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will take place on or around 3 January 2014.

 

Following Admission, the Company will have 390,700,441 ordinary shares in issue ("Issued Share Capital"). This figure may be used by shareholders in Blue Star as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Issued Share Capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

Anthony Fabrizi will be interested in 9,426,203 ordinary shares in the Company representing 2.4 per cent of the Issued Share Capital.

 

 

Related Party Transaction

 

Anthony Fabrizi, Chief Executive Officer of the Company, is amongst those that provided the Loan and is a related party for the purposes of AIM Rule 13. Graham Parr, the independent director of the Company considers, having consulted with the Company's nominated adviser Daniel Stewart & Company plc ("Daniel Stewart"), that the terms of the repayment of the Loan are fair and reasonable insofar as the Company's shareholders are concerned.

 

 

Ends

 

 

Contacts:

Blue Star Capital plc

Tony Fabrizi

Tel: +44 777 178 2434

Daniel Stewart & Company plc

Nominated Adviser & Broker

David Hart/Ciaran Walsh/Martin Lampshire

Tel: +44 20 7776 6550

 

Square1 Consulting

David Bick/Mark Longson

+44 207 929 5599

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFKLFLXLFEFBX
Date   Source Headline
29th Apr 20247:00 amRNSDynasty Update
18th Apr 20247:00 amRNSResult of AGM
15th Apr 202412:00 pmRNSHolding(s) in Company
28th Mar 20247:00 amRNSFurther re Pendulum: Spacewalk launch on Pendulum
21st Mar 20247:01 amRNSFinal Results
13th Mar 20247:00 amRNSDynasty Gaming and Media Merger
16th Feb 20243:00 pmRNSHolding(s) in Company
19th Jan 20244:25 pmRNSFurther re: Fundraise
17th Jan 20247:00 amRNSFundraise, Issue of Warrants & Broker Appointment
16th Jan 20247:00 amRNSPortfolio Update
27th Nov 20237:00 amRNSDynasty Update
15th Nov 20237:00 amRNSSatoshiPay Update
9th Oct 20239:08 amRNSDirectorate Change
28th Jun 20237:00 amRNSHalf-year Report
1st Jun 20239:32 amRNSPendulum: Spacewalk bridge released on Amplitude
2nd May 20237:00 amRNSDynasty Launches Partnership with Lets Play Live
3rd Apr 20237:00 amRNSResult of AGM
14th Mar 20237:00 amRNSPendulum Announces Blockchain Bridge
7th Mar 20237:00 amRNSFinal Results
14th Feb 20234:56 pmRNSHolding(s) in Company
14th Feb 20237:00 amRNSPendulum Mainnet Launch
30th Jan 20237:00 amRNSGrant of Warrants
30th Dec 20227:00 amRNSHolding(s) in Company
23rd Dec 20227:00 amRNSPendulum Completes Crowdloan
25th Nov 20224:53 pmRNSTR-1: Standard notification of major holdings
25th Nov 20222:47 pmRNSHolding(s) in Company
31st Oct 20227:49 amRNSDynasty Investment Update
5th Oct 20224:18 pmRNSHolding(s) in Company
28th Sep 20227:00 amRNSTrading Update and Investment Portfolio Review
27th Sep 20227:15 amRNSGuild Reduces David Beckham Payment Obligations
26th Sep 20227:12 amRNSGuild Signs Sponsorship Deal with Sky UK
23rd Sep 202210:19 amRNSHolding(s) in Company
21st Sep 20227:00 amRNSHolding(s) in Company
16th Sep 20227:36 amRNSDirectorate Changes
16th Sep 20227:00 amRNSDirectorate Changes
8th Sep 20227:00 amRNSHolding(s) in Company
15th Aug 202212:05 pmRNSTR-1: Standard notification of major holdings
30th Jun 20227:00 amRNSHalf-year Report
19th Apr 20221:37 pmRNSResult of AGM
11th Apr 20221:09 pmRNSHolding(s) in Company
7th Apr 20227:00 amRNSDynasty Gaming & Media new partnership agreements
25th Mar 20221:00 pmRNSFinal Results
9th Mar 20222:00 pmRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSHolding(s) in Company
20th Jan 202211:05 amRNSSecond Price Monitoring Extn
20th Jan 202211:00 amRNSPrice Monitoring Extension
18th Jan 20227:14 amRNSGuild Sponsorship Deal
17th Jan 20227:00 amRNSSatoshiPay Directorate Changes and Update
6th Jan 202212:07 pmRNSHolding(s) in Company
5th Jan 20227:00 amRNSStatement re Share Price Movement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.